Real-time funding, M&A, exec moves & hiring — the signals that move deals
The intelligence a $25K terminal charges for — the day it breaks, in your market, at a fraction of the price.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Abbott Laboratories
abbott.comAI Executive Summary
AI-powered analysis of 8-K filing content
Abbott Laboratories issued $20 billion in senior notes across multiple tranches on March 9, 2026, to strengthen its financial position and provide liquidity for operations and growth initiatives.
Key Takeaways
Abbott raised $20 billion through a public offering of senior notes with maturities ranging from 2029 to 2033
The offering included four tranches: $1B floating rate notes due 2029, $2.25B at 3.700% due 2029, $2.5B at 4.000% due 2031, and $2.75B at 4.300% due 2033
2 more takeaways
Related Filings (2)
2 more filings from Abbott Laboratories in the last 90 days